Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-14

Clinical Trial Update: Remifentanil and Glycemic Response in Cardiac Surgery [Phase 4]

View source ↗

Summary

A phase 4 clinical trial assessed remifentanil's effect on glycemic response in patients undergoing cardiac surgery; study status completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)

Snippet

Sponsor: Kathirvel Subramaniam | Conditions: Heart Diseases, Hyperglycemia | Phase 4 | Status: COMPLETED | Results posted: 2018-05-14